Non-viral siRNA delivery into the mouse retina in vivo

BMC Ophthalmology

Volumn 10, Issue 1, 2010, Pages

  Turchinovich, Andrey ^a   Zoidl, Georg ^a   Dermietzel, Rolf ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; GREEN FLUORESCENT PROTEIN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; GLIA; IMMUNOHISTOCHEMISTRY; INTRAVITREAL DRUG ADMINISTRATION; METABOLISM; MOUSE; RETINA;

ANIMALS; DISEASE MODELS, ANIMAL; GENE SILENCING; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; INTRAVITREAL INJECTIONS; MICE; MICE, INBRED C57BL; NEUROGLIA; RETINA; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77957194820     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-10-25     Document Type: Article

References (17)

1. Interfering with disease: a progress report on siRNA-based therapeutics. A de Fougerolles HP Vornlocher J Maraganore J Lieberman, Nat Rev Drug Discov 2007 6 443 453 10.1038/nrd2310 17541417
2. Challenges in non-viral ocular gene transfer. L Peeters NN Sanders J Demeester SC De Smedt, Biochem Soc Trans 2007 35 47 49 10.1042/BST0350047 17233598
3. Electroporation and RNA interference in the rodent retina in vivo and in vitro. T Matsuda CL Cepko, Proc Natl Acad Sci USA 2004 101 16 22 10.1073/pnas.2235688100 14603031
4. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. L Pitkanen J Pelkonen M Ruponen S Ronkko A Urtti, AAPS J 2004 6 25 10.1208/aapsj060325 15760110
5. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. L Pitkanen M Ruponen J Nieminen A Urtti, Pharm Res 2003 20 576 583 10.1023/A:1023238530504 12739764
6. Vitreous: a barrier to nonviral ocular gene therapy. L Peeters NN Sanders K Braeckmans K Boussery J Van de Voorde SC De Smedt J Demeester, Invest Ophthalmol Vis Sci 2005 46 3553 3561 10.1167/iovs.05-0165 16186333
7. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. J Shen R Samul RL Silva H Akiyama H Liu Y Saishin SF Hackett S Zinnen K Kossen K Fosnaugh,, et al. Gene Ther 2006 13 225 234 10.1038/sj.gt.3302641 16195704
8. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. ME Kleinman K Yamada A Takeda V Chandrasekaran M Nozaki JZ Baffi RJ Albuquerque S Yamasaki M Itaya Y Pan,, et al. Nature 2008 452 591 597 10.1038/nature06765 18368052
9. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. WG Cho RJ Albuquerque ME Kleinman V Tarallo A Greco M Nozaki MG Green JZ Baffi BK Ambati M De Falco,, et al. Proc Natl Acad Sci USA 2009 106 7137 7142 10.1073/pnas.0812317106 19359485
10. Liquid chromatography electrospray ionization mass spectrometry analysis of the ocular metabolites from a short interfering RNA duplex. M Beverly K Hartsough L Machemer P Pavco J Lockridge, J Chromatogr B Analyt Technol Biomed Life Sci 2006 835 62 70 10.1016/j.jchromb.2006.03.008 16574504
11. Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats. Y Hou L Xing S Fu X Zhang J Liu H Liu B Lv H Cui, Graefes Arch Clin Exp Ophthalmol 2009 247 755 765 10.1007/s00417-008-1023-0 19125271
12. In vivo gene delivery in the retina using polyethylenimine. HW Liao KW Yau, Biotechniques 2007 42 285 286 288 10.2144/000112404 17390533
13. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. SJ Reich J Fosnot A Kuroki W Tang X Yang AM Maguire J Bennett MJ Tolentino, Mol Vis 2003 9 210 216 12789138
14. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. H Nakamura SS Siddiqui X Shen AB Malik JS Pulido NM Kumar BY Yue, Mol Vis 2004 10 703 711 15475878
15. Inhibition of respiratory viruses by nasally administered siRNA. V Bitko A Musiyenko O Shulyayeva S Barik, Nat Med 2005 11 50 55 10.1038/nm1164 15619632
16. Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. S Friedrich YL Cheng B Saville, Curr Eye Res 1997 16 663 669 10.1076/ceyr.16.7.663.5061 9222083 (Pubitemid 27322718)
17. Quantitative analysis of intravitreal injections in the rat. P Dureau S Bonnel M Menasche JL Dufier M Abitbol, Curr Eye Res 2001 22 74 77 10.1076/ceyr.22.1.74.6974 11402382